Angiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice.
about
Intracellular delivery of biologic therapeutics by bacterial secretion systems.Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads.
P2860
Angiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiogenic inhibitors delivere ...... safely shrink tumors in mice.
@en
Angiogenic inhibitors delivere ...... safely shrink tumors in mice.
@nl
type
label
Angiogenic inhibitors delivere ...... safely shrink tumors in mice.
@en
Angiogenic inhibitors delivere ...... safely shrink tumors in mice.
@nl
prefLabel
Angiogenic inhibitors delivere ...... safely shrink tumors in mice.
@en
Angiogenic inhibitors delivere ...... safely shrink tumors in mice.
@nl
P2093
P2860
P1433
P1476
Angiogenic inhibitors delivere ...... safely shrink tumors in mice.
@en
P2093
P2860
P2888
P356
10.1186/S13568-016-0226-8
P50
P577
2016-08-24T00:00:00Z
P6179
1000193200